Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 15/20 | 1.00 |
| ▸ | PDE4B | Q07343 | 15/20 | 1.00 |
| ▸ | PDE4C | Q08493 | 15/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 15/20 | 1.00 |
| ▸ | TNF | P01375 | 7/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5905223 | 0.94 | PDE4A (0.89) | PDE4APDE4BPDE4CPDE4DTNF | |
| SCHEMBL5905090 | 0.92 | PDE4A (1.00) | PDE4APDE4BPDE4CPDE4DTNF | |
| SCHEMBL8640250 | 0.91 | PDE4A (0.84) | PDE4APDE4BPDE4CPDE4DTNF | |
| SCHEMBL2992015 | 0.89 | PDE4B (0.80) | PDE4APDE4BPDE4CPDE4DTNF | |
| SCHEMBL6555476 | 0.89 | PDE4B (0.80) | PDE4APDE4BPDE4CPDE4DTNF | |
| SCHEMBL14402820 | 0.89 | PDE4A (0.80) | PDE4APDE4BPDE4CPDE4DTNF | |
| SCHEMBL13699741 | 0.89 | PDE4A (0.79) | PDE4APDE4BPDE4CPDE4DTNF | |
| SCHEMBL31062863 | 0.89 | PDE4A (0.79) | PDE4APDE4BPDE4CPDE4DTNF | |
| SCHEMBL8637015 | 0.88 | PDE4B (0.78) | PDE4APDE4BPDE4CPDE4DTNF | |
| SCHEMBL8327774 | 0.88 | PDE4A (0.78) | PDE4APDE4BPDE4CPDE4DTNF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5728845-A | TUMOR NECROSIS FACTOR AND PHOSPHODIESTERASE INHIBITORS | CELGENE CORPORATION (US) | 1998-03-17 | — | — | US | claimed |
| EP-0851857-B1 | INHIBITORS OF TUMOR NECROSIS FACTOR ALPHA | CELGENE CORP (US) | 2004-02-18 | — | — | EP | disclosed |
| EP-1367051-A2 | Inhibitors of tumor necrosis factor alpha | CELGENE CORPORATION (US) | 2003-12-03 | — | — | EP | disclosed |
| EP-0957091-B1 | Inhibitors of tumor necrosis factor alpha | CELGENE CORP (US) | 2003-06-04 | — | — | EP | disclosed |
| EP-0957091-A1 | Inhibitors of tumor necrosis factor alpha | CELGENE CORPORATION (US) | 1999-11-17 | — | — | EP | disclosed |
| EP-0851857-A1 | INHIBITORS OF TUMOR NECROSIS FACTOR ALPHA | CELGENE CORPORATION (US) | 1998-07-08 | — | — | EP | disclosed |
| WO-1997008143-A1 | INHIBITORS OF TUMOR NECROSIS FACTOR ALPHA | CELGENE CORPORATION (US) | 1997-03-06 | — | — | WO | disclosed |